The 10th Doctor Problem: Why MCAS Patients Keep Getting the Wrong Diagnosis

In my office, the patient who comes in is rarely the first doctor’s opinion. They’re the fourth. The seventh. Sometimes the tenth.

By the time they reach me, they’ve been told they have IBS, anxiety, a viral infection that should have passed months ago, or — most dismissively — that their test results are normal and they should focus on stress management.

They’re not wrong that something is happening. Their doctors just didn’t have a framework to recognize it.

Mast cell activation syndrome (MCAS) is one of the most underrecognized multi-system conditions in medicine, and the pattern of misdiagnosis follows a predictable logic. Understanding why it’s missed helps patients advocate more effectively — and helps clinicians catch it earlier.

What MCAS Patients Say When They Walk In

The symptom picture that brings someone to my office usually involves multiple organ systems simultaneously — and that’s precisely why it gets misattributed repeatedly.

The most common presenting symptoms:

Skin: Recurrent hives, flushing, and rashes that come and go without an obvious external cause. Dermatologists treat the skin. They don’t always investigate why it keeps happening.

Gastrointestinal: Bloating, diarrhea, constipation, and abdominal pain. Gastroenterologists evaluate for structural or bacterial causes — IBS, SIBO, Crohn’s — but often don’t consider an immune mechanism when those workups are negative.

Neurological: Brain fog, increased anxiety, poor memory, and migraine headaches. These symptoms, when they appear alongside GI complaints, often result in a mental health referral. The patient is told their symptoms are anxiety-driven. They’re not wrong that anxiety makes things worse — stress activates mast cells through cortisol receptors — but anxiety isn’t the root cause.

Respiratory: Chronic coughing, wheezing, or throat tightness that doesn’t respond to asthma treatment.

Cardiovascular: Elevated heart rate, blood pressure fluctuations, or near-syncope on standing (a POTS presentation).

The critical pattern: when skin, GI, neurological, and cardiovascular symptoms occur together in a patient with no clear cause, mast cell activation syndrome should be on the differential. Food poisoning doesn’t cause a rash. A viral infection doesn’t cause persistent multi-system reactivity for months. IBS doesn’t make a patient react to perfume.

The Most Common Wrong Diagnoses

Food poisoning — When a patient has a reaction that involves GI upset and hives after eating, particularly a delayed reaction (common with alpha-gal syndrome, a related tick-borne condition), the default assumption is food poisoning. Food poisoning doesn’t typically produce skin symptoms. That combination should prompt a different investigation.

Viral infection — In urgent care settings, “this will pass, take some Tylenol” is a frequent response to acute multi-system symptoms with no obvious cause. When the symptoms don’t pass — when the same thing keeps happening — this diagnosis has been given without adequate investigation.

IBS — The diagnosis applied when GI symptoms are chronic and lab workup is unremarkable. IBS is a diagnosis of exclusion. In many patients, it should prompt investigation into candida overgrowth, SIFO, or gut-driven mast cell activation — not a permanent label that ends the diagnostic process.

Anxiety disorder — Brain fog, increased anxiety, and cognitive symptoms that accompany physical illness are frequently attributed to mental health conditions rather than investigated as potential consequences of immune dysregulation. The brain fog in MCAS is neurological — mast cells are present in the brain’s vasculature, histamine receptors are in the brain, and inflammation at those sites produces real cognitive symptoms.

Generalized “allergies” — Some patients are told they have allergies and given antihistamines without further investigation. Antihistamines may reduce some symptoms without addressing the underlying cause, creating the illusion that the condition is managed when it isn’t.

Why MCAS Is So Hard to Diagnose Conventionally

The diagnostic difficulty is real and has structural causes.

Mast cells aren’t in the blood. Standard blood panels measure white blood cells — T cells, B cells, neutrophils. Mast cells live in tissue. To directly observe mast cell numbers, you’d need biopsies from multiple tissue sites — not a practical clinical workup. The cells causing the problem are essentially invisible to routine testing.

Lab markers are often normal. Tryptase — elevated in mast cell activation — is transient. It peaks during an active reaction and normalizes quickly. Prostaglandin D2 in urine is another useful marker, but it’s not part of standard panels and requires specific ordering. The majority of MCAS patients I see have completely normal routine labs. Normal labs do not mean nothing is wrong.

Symptoms mimic too many other conditions. Hives alone could be urticaria. GI symptoms alone could be IBS. Fatigue alone could be dozens of things. It’s the combination — the simultaneous involvement of multiple organ systems, the reactivity to chemical exposures, the pattern of reactions — that points to MCAS. Specialists who see only their organ system miss the pattern.

The Chemical Sensitivity Connection

One presentation that’s particularly poorly served by conventional medicine is multiple chemical sensitivity — the inability to tolerate perfumes, cleaning products, car exhaust, certain building environments.

Like brain fog before COVID, chemical sensitivity was long dismissed as psychosomatic. Patients were told it wasn’t a real diagnosis.

Dr. Claudia Miller, a pioneer in environmental medicine, has demonstrated that multiple chemical sensitivity and MCAS are effectively two presentations of the same underlying biology. These patients’ mast cells are reacting to chemical exposures just as they react to allergens or toxins — through the same receptor-mediated cascade, with the same mediator release.

A patient who can’t be in a hotel lobby without reacting to the scent system, who develops symptoms in recently renovated buildings, who can’t tolerate certain cleaning products — that patient may have MCAS, not a psychological condition. They need investigation, not reassurance that nothing is wrong.

What Finally Gets Patients to the Right Clinician

Two patterns.

The first: the accumulation of enough experiences that they no longer accept the “everything is normal” conclusion. They’ve tracked their reactions. They’ve noticed the pattern. They’re ready to push for a different evaluation.

The second: AI tools. I’ve seen a meaningful shift in recent years in the type of patient who arrives knowing to ask about MCAS. Patients are entering their full symptom list — multi-organ, multi-system, reactive to multiple environmental triggers — into ChatGPT, Claude, or Gemini. These tools, when given a comprehensive symptom picture, increasingly surface MCAS as a condition to investigate.

I find this genuinely useful. These patients have often spent years being dismissed. If a language model helps them arrive at the right clinical conversation sooner, that’s a meaningful outcome.

The most important thing I can offer someone who recognizes this pattern: the multi-system presentation you’ve been told doesn’t make sense is actually coherent. There is a mechanism. There is a diagnosis. And there is a treatment approach. You are not anxious, and you are not imagining it.

Frequently Asked Questions

Q: What’s the single best reason to suspect MCAS rather than multiple separate conditions?

The reactivity pattern across multiple triggers and organ systems simultaneously. If a patient reacts to foods, chemicals, environmental exposures, and stress — all with overlapping skin, GI, and neurological symptoms — the most parsimonious explanation is a single dysregulated system affecting all of them, not a separate diagnosis for each.

Q: Why do my lab results come back normal if I’m so clearly sick?

MCAS is a condition of dysregulated mast cell behavior, not abnormal mast cell numbers. Standard bloodwork measures white blood cell subtypes, not mast cell function. Tryptase and prostaglandin D2 markers are transient and require specific testing during or shortly after an acute reaction to capture. Most patients will have normal routine labs.

Q: How many doctors should I see before pushing for an MCAS evaluation?

There’s no specific number, but if you’ve seen multiple specialists for overlapping symptoms across different organ systems and received no unifying diagnosis — or if you’ve been diagnosed with IBS, chronic urticaria, and anxiety simultaneously as separate conditions — requesting a mast cell evaluation is warranted.

Q: Is MCAS a real diagnosis recognized by mainstream medicine?

Yes. MCAS was formally defined in the medical literature beginning around 2007-2010 and has been accepted by major allergy, immunology, and mastocytosis research organizations, including The Mastocytosis Society. Diagnostic criteria exist, though they continue to evolve as understanding deepens.